Preventing infections in ICU patients on ventilators
Part of Infections clinical trials.
This trial tests an experimental drug called Fluorothiazinone to prevent serious bacterial infections in ICU patients who are on a breathing machine (ventilator) or likely to need one soon. It includes patients with COVID-19 pneumonia, stroke, or heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and in the Intensive Care Unit (ICU).
- You have either COVID-19 with severe pneumonia, a recent stroke, or acute heart failure.
- If you are on a breathing machine (ventilator), it has been for less than 12 hours.
- You are expected to need a ventilator within the next 3 days.
- You and your partner (if applicable) agree to use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving antibiotics based on a patient's unique gut bacteria can prevent pneumonia in people who are on a breathing machine (ventilator) in the intensive care unit (ICU). It aims to see if this personalized approach is more effective than standard care.
This early (Phase 1) study tests AVM0703 in adults who are very sick with lung failure caused by COVID-19 or influenza (flu). It aims to see if the treatment is safe and potentially helpful when standard rescue breathing treatments are not enough.
This study tests an inhaled study drug (SNG001) for adults on a breathing machine in the ICU due to a viral lung infection. The goal is to see if the drug can help patients recover faster.
This study tests two different mouth-care solutions for patients on breathing machines, to see if they can prevent pneumonia and improve mouth health in intensive care.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
This trial tests whether a medicine called interferon gamma can improve outcomes in adults with a first episode of pneumonia that develops after being on a ventilator in the ICU. It is designed for specific ICU timing, infection severity, and immune marker levels, and it compares treatment on top of standard care.
Hear when a new Gram-Negative Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.